Apoptosis, Bcl-2, and proliferating cell nuclear antigen in the failing human heart: Observations made after implantation of left ventricular assist device

Journal of Cardiac Failure

Volumn 5, Issue 4, 1999, Pages 308-315

  Francis, Gary S ^a,c   Anwar, Faten ^b   Bank, Alan J ^a   Kubo, Spencer H ^a   Jessurun, Jose ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Apoptosis; Bcl 2; Heart failure; LVAD; Remodeling

Indexed keywords

CYCLINE; PROTEIN BCL 2;

ADULT; APOPTOSIS; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HEART ASSIST DEVICE; HEART FAILURE; HEART LEFT VENTRICLE; HEART VENTRICLE REMODELING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMPLANTATION; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0033372660     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-9164(99)91335-0     Document Type: Article

References (25)

1. Olivetti G, Melissari M, Capasso JM, Anversa P: Cardiomyopathy of the aging human heart, myocyte loss and reactive cellular hypertrophy. Circ Res 1991;68:1560-8
2. Beltrami CA, Finato N, Rocco M, Feruglio GA, Puricelli C, Cigola E, Quaini F, Sonnenblick EH, Olivetti G, Anversa P: Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation 1994;89:151-63
3. Beltrami CA, Finato N, Rocco M, Feruglio GA, Puricelli C, Cigola E, Sonnenblick EH, Olivetti G, Anversa P: The cellular basis of dilated cardiomyopathy in humans. J Mol Cell Cardiol 1995;27:291-305
4. Nanila J, Haider N, Virmani R, DiSalvo TG, Kolodgie FD, Hajjar RJ, Schmidt U, Semigran MJ, Dec GW, Khaw B-A: Apoptosis in myocytes in end-stage heart failure. N Engl J Med 1996;335:1182-9
5. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, Quaini E, DiLoreto C, Beltrami CA, Krajewski S, Reed JC, Anversa P: Apoptosis in the failing human heart. N Engl J Med 1997;336:1131-41
6. Bursch W, Oberhammer F, Schulte-Hermann R: Cell death by apoptosis and its protective role against disease. Trends Pharmacol Sci 1992;13:245-51
7. James TN: Normal and abnormal consequences of apoptosis in the human heart: from postnatal morphogenesis to paroxysmal arrhythmias. Circulation 1994;90:556-73
8. Sanders-Williams R: Apoptosis and heart failure. N Engl J Med 1999;341:759-60
9. Cheng W, Li B, Kajstura J, Li P, Wolin M, Sonnenblick EH, Hintze TH, Olivetti G, Anversa P: Stretch-induced programmed myocyte cell death. J Clin Invest 1995;96: 2247-59
10. Li Z, Bing OHL, Long X, Robinson KG, Kakatta EG: Increased cardiomyocyte apoptosis during the transition to heart failure in the spontaneously hypertensive rat. Am J Physiol 1997;272:H2313-9
11. Misao J, Hayakawa Y, Ohno M, Kato S, Fujiwara T, Fujiwara H: Expression of bcl-2 protein, an inhibitor of apoptosis, and Bax, an accelerator of apoptosis, in ventricular myocytes of human hearts with myocardial infarction. Circulation 1996;94:1506-12
12. Levin HR, Oz MC, Chen JM, Packer M, Rose EA, Burkhoff D: Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading. Circulation 1995;91:2717-20
13. Kakatani S, McCarthy PM, Kottke-Marchang K, Harasaki H, James KB, Savage RM, Thomas JD: Left ventricular echocardiographic and histologic changes: impact of chronic unloading by an implantable ventricular assist device. J Am Coll Cardiol 1996;27:894-901
14. Oz MC, Rose EA, Levin HR: Selection criteria for placement of left ventricular assist devices. Am Heart J 1995;129:173-7
15. Kerr JF, Wylie AH, Currie AF: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239-57
16. Wyllie AH: Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980;284:555-6
17. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456-62
18. Yeh ETH: Life and death in the cardiovascular system. Circulation 1997;95:782-6
19. Vaux DL, Haecker G, Strasser A: An evolutionary perspective on apoptosis. Cell 1994;76:777-9
20. Hetts SW: To die or not to die: an overview of apoptosis and its role in disease. JAMA 1998;279:300-7
21. Yasuda M, Umemura S, Osamura Y, Kenjo T, Tsutsumi Y: Apoptotic cells in the human endometrium and placental villi: pitfalls in applying in TUNEL method. Arch Histol Cytol 1995;58:185-90
22. Kockx MM, Muhring J, Knaapen MWM, de Mayer GRY: RNA synthesis and splicing interferes with DNA in situ end-labeling techniques used to detect apoptosis. Am J Pathol 1998;152:885-8
23. Kanoh M, Takemura G, Misao J, Hayakawa Y, Aoyama T, Nishigaki K, Noda T, Fujiwara T, Fukuda K, Munatoguchi S, Fujiwara H: Significance of myocytes with positive DNA in situ nick end-labeling (TUNEL) in hearts with dilated cardiomyopathy. Not apoptosis but DNA repair. Circulation 1999;99:2757-64
24. Kirshenbaum LA, de Moissac D: The bcl-2 gene product prevents programmed cell death of ventricular myocytes. Circulation 1997;96:1580-5
25. Kroemer G: Ther proto-oncogene BCL-2 and its role in regulating apoptosis. Nat Med 1997;3:614-20